Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Innate Pharma reports positive Phase I/II trial data of monalizumab for advanced gynecologic malignancies

Go Top